{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:42Z","timestamp":1793327442654,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1434800"],"award-info":[{"award-number":["23ZR1434800"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YG2025ZD12"],"award-info":[{"award-number":["YG2025ZD12"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0909000"],"award-info":[{"award-number":["2020YFA0909000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272044"],"award-info":[{"award-number":["82272044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371997"],"award-info":[{"award-number":["82371997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124605","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:27:44Z","timestamp":1788503264000},"page":"124605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["FAP-targeted gold nanocluster-mediated radioligand therapy in combination with TGF-\u03b2RI inhibition for tumor therapy"],"prefix":"10.1016","volume":"338","author":[{"given":"Huizhen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangxi","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-415X","authenticated-orcid":false,"given":"Chunfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biomaterials.2026.124605_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41571-025-01069-z","article-title":"The molecular blueprint of targeted radionuclide therapy","volume":"22","author":"Primac","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124605_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124605_bib5","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.apsb.2022.03.009","article-title":"Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development","volume":"12","author":"Lai","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41420-023-01778-3","article-title":"Carrier systems of radiopharmaceuticals and the application in cancer therapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"8015","key":"10.1016\/j.biomaterials.2026.124605_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124605_bib8","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.123.266381","article-title":"Preclinical evaluation of a radiotheranostic single-domain antibody against fibroblast activation protein \u03b1","volume":"64","author":"Dekempeneer","year":"2023","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.123.265599","article-title":"Development of FAPI tetramers to improve tumor uptake and efficacy of FAPI radioligand therapy","volume":"64","author":"Pang","year":"2023","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"key":"10.1016\/j.biomaterials.2026.124605_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114543","article-title":"Tumor targeted radionuclide-nanomedicine for clinical translation: from carrier innovation to precision therapy","volume":"390","author":"Wei","year":"2026","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124605_bib11","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/anie.201807847","article-title":"Renal clearable luminescent gold nanoparticles: from the bench to the clinic","volume":"58","author":"Yu","year":"2019","journal-title":"Angew. Chem."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124605_bib12","article-title":"Nanomedicine reimagined: translational strategies for precision tumor theranostics","volume":"38","author":"Wu","year":"2026","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/adhm.201300189","article-title":"Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy","volume":"3","author":"Zhang","year":"2014","journal-title":"Adv. Healthcare Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124605_bib14","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1039\/D2CS00497F","article-title":"Emerging ultrasmall luminescent nanoprobes for in vivo bioimaging","volume":"52","author":"Li","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2026.124605_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2015.12.012","article-title":"Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements","volume":"109","author":"Her","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124605_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101144","article-title":"Radionuclide labeled gold nanoclusters boost effective anti-tumor immunity for augmented radio-immunotherapy of cancer","volume":"38","author":"Pei","year":"2021","journal-title":"Nano Today"},{"issue":"32","key":"10.1016\/j.biomaterials.2026.124605_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv. Mater."},{"issue":"34","key":"10.1016\/j.biomaterials.2026.124605_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201900968","article-title":"Targeted gold nanocluster-enhanced radiotherapy of prostate cancer","volume":"15","author":"Luo","year":"2019","journal-title":"Small"},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124605_bib19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/smll.201600194","article-title":"Dynamic positron emission tomography imaging of renal clearable gold nanoparticles","volume":"12","author":"Chen","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124605_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112291","article-title":"One-pot synthesis of 68Ga-doped ultrasmall gold nanoclusters for PET\/CT imaging of tumors","volume":"128","author":"Zheng","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biomaterials.2026.124605_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101144","article-title":"Radionuclide labeled gold nanoclusters boost effective anti-tumor immunity for augmented radio-immunotherapy of cancer","volume":"38","author":"Pei","year":"2021","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124605_bib22","article-title":"Ultrasmall Au(10-12) nanoclusters: a novel platform for (223)Ra-Targeted tumor \u03b1-Therapy","volume":"6","author":"Jiang","year":"2026","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2026.124605_bib23","article-title":"pH-sensitive gold nanoclusters labeling with radiometallic nuclides for diagnosis and treatment of tumor","volume":"19","author":"Jiang","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124605_bib24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies","volume":"50","author":"Priv\u00e9","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124605_bib25","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib26","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.apsb.2025.07.009","article-title":"Fibroblast activation protein targeting radiopharmaceuticals: from drug design to clinical translation","volume":"15","author":"Wu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib27","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124605_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170490","article-title":"68Ga-FAPI PET imaging monitors response to combined TGF-\u03b2R inhibition and immunotherapy in metastatic colorectal cancer","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124605_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124605_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124605_bib32","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","article-title":"Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond","volume":"49","author":"Li","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib33","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.7150\/thno.106108","article-title":"Therapeutic potential of FAPI RLT in oncology: a systematic review","volume":"15","author":"Ruzzeh","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124605_bib34","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00259-025-07711-3","article-title":"Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective","volume":"53","author":"Wu","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.120.258467","article-title":"(68)Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: Comparison with (18)F-FDG PET\/CT","volume":"63","author":"Qin","year":"2022","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124605_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00259-021-05554-2","article-title":"Fibroblast activation protein targeted therapy using [(177)Lu]FAPI-46 compared with [(225)Ac]FAPI-46 in a pancreatic cancer model","volume":"49","author":"Liu","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124605_bib37","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-021-05653-0","article-title":"Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA","volume":"49","author":"Backhaus","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"36","key":"10.1016\/j.biomaterials.2026.124605_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/advs.75150","article-title":"A FAP-targeted SMDC platform enables synergistic radionuclide-chemotherapy with PET-guided evaluation","volume":"13","author":"Yang","year":"2026","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124605_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2967\/jnumed.121.263016","article-title":"Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of (68)Ga-Labeled FAPI dimer","volume":"63","author":"Zhao","year":"2022","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124605_bib40","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7150\/thno.68182","article-title":"Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics","volume":"12","author":"Wen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124605_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2021.08.002","article-title":"The transformation of cancer-associated fibroblasts: current perspectives on the role of TGF-\u03b2 in CAF mediated tumor progression and therapeutic resistance","volume":"520","author":"Chandra Jena","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124605_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-021-00302-5","article-title":"TGF-\u03b21-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biomaterials.2026.124605_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155709","article-title":"TGF-beta signaling in cancer radiotherapy","volume":"148","author":"Wang","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.biomaterials.2026.124605_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114527","article-title":"TGF-\u03b21-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-\u03b1","volume":"188","author":"Huang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"7693","key":"10.1016\/j.biomaterials.2026.124605_bib47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124605_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth Factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124605_bib49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124605_bib51","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cm304098x","article-title":"Scalable and precise synthesis of thiolated Au10\u201312, Au15, Au18, and Au25 nanoclusters via pH controlled CO reduction","volume":"25","author":"Yu","year":"2013","journal-title":"Chem. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib52","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based Theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124605_bib53","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41565-019-0527-6","article-title":"Renal clearable catalytic gold nanoclusters for in vivo disease monitoring","volume":"14","author":"Loynachan","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124605_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/nano11071702","article-title":"Pharmacokinetics, biodistribution, and biosafety of PEGylated gold nanoparticles in vivo","volume":"11","author":"Kozics","year":"2021","journal-title":"Nanomaterials"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124605_bib57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124605_bib58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41419-023-06060-z","article-title":"Cancer-associated fibroblasts: tumor defenders in radiation therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib59","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124605_bib60","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124605_bib61","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41571-022-00682-6","article-title":"Towards precision oncology with patient-derived xenografts","volume":"19","author":"Zanella","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124605_bib62","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.semnuclmed.2025.06.010","article-title":"[177Lu]Lu-FAPI radioligand therapy: emerging Horizons and clinical promise in solid tumors: a comprehensive review","volume":"55","author":"Al-Ibraheem","year":"2025","journal-title":"Semin. Nucl. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124605_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124605_bib64","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-024-01853-w","article-title":"Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124605_bib66","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1021\/ja401612x","article-title":"Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance","volume":"135","author":"Liu","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124605_bib67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2967\/jnumed.115.159012","article-title":"MIRD pamphlet No. 26: joint EANM\/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy","volume":"57","author":"Ljungberg","year":"2016","journal-title":"J. Nucl. Med. : official publication, Society of Nuclear Medicine"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:35:41Z","timestamp":1793324141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":67,"alternative-id":["S0142961226006290"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124605","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FAP-targeted gold nanocluster-mediated radioligand therapy in combination with TGF-\u03b2RI inhibition for tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124605"}}